Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 82
- Developing broad-spectrum antiviral drugs for pandemic preparednessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- New AntiVirals for Infections with Pandemic PotentialFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- European Viral Outbreak Response AllianceFrom1 Jan 2024 → TodayFunding: HORIZON.1.3 - Research Infrastructures
- Classic and new strategies to fight alphavirusesFrom18 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Towards strategies for the treatment and prevention of henipavirus infections.From21 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- HTS to discover direct-acting small molecule inhibitors of henipavirusesFrom16 Nov 2022 → TodayFunding: Foreign private sponsor - undefined
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- VirusBank platform (state-of-the-art research platform for increased preparedness against viral epidemics and pandemics)From1 Jan 2022 → TodayFunding: Ministery of Economical Affairs
Publications
21 - 30 of 621
- Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects(2023)
Authors: Dirk Jochmans, Johan Neyts, Steven De Jonghe, Pieter Leyssen
- Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents(2023)
Authors: Johan Neyts, Dirk Jochmans, Graciela Andrei, Robert Snoeck
Pages: 2147 - 2159 - Comprehensive study of alkaloids from Scadoxus multiflorus by HPLC-PDA-SPE-NMR and evaluation of their anti-SARS-CoV-2 activity(2023)
Authors: Steven De Jonghe, Johan Neyts, Christophe Pannecouque
Pages: 156 - 162 - Moral-oids: An Ethical Exploration of Organoid Models in Biomedical Research(2023)
Authors: Andrew Barnhart, Kris Dierickx, Johan Neyts
- Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies(2023)
Authors: Tania Roskams, Lotte Coelmont, Johan Neyts, Suzanne Kaptein
- YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge(2023)
Authors: Viktor Lemmens, Lara Kelchtermans, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Kai Dallmeier
- Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors(2023)
Authors: Suzanne Kaptein, Johan Neyts
Pages: 8808 - 8821 - Antiviral strategies for epidemic and pandemic preparedness(2023)
Authors: Dirk Jochmans, Manon Laporte, Johan Neyts
Pages: 856 - 860 - Reverse engineering synthetic antiviral amyloids (vol 11, 2832, 2020)(2023)
Authors: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
- Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks(2023)
Authors: Lize Cuypers, Sam Hong, Sarah Gorissen, Bert Vanmechelen, Pieter Vermeersch, Katrien Lagrou, Marc Van Ranst, Johan Neyts, Guy Baele, Piet Maes, et al.
Pages: 722 - 733
Patents
1 - 10 of 10
- Corona virus binders (Inventor)
- Lassavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Coronavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Treatment and prevention of dengue disease (Inventor)